22 . 03 .2021
Press release
Cetaphil® Launches Innovative Digital Campaign to Connect with Millions of Consumers Experiencing Skin Sensitivity
10 . 03 .2021
Press release
Galderma online survey reveals almost two thirds of rosacea patients* are experiencing worsening of signs and symptoms related to essential COVID-19 mask wearing
08 . 03 .2021
Press release
Differin® Celebrates Fourth Annual Retinoid Education Week by Offering People with Acne the Chance to “Get Clear” Through Large-Scale Product Giveaway
04 . 03 .2021
Press release
Galderma continues global growth ambition with Sculptra® (injectable poly-L-lactic acid) re-launch in Europe
04 . 02 .2021
Press release
Galderma receives FDA approval for Restylane® Defyne for chin augmentation
18 . 11 .2020
Press release
Galderma launches Dysport® in China for treatment of glabellar lines
17 . 11 .2020
Press release
Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)
13 . 10 .2020
Press release
Cetaphil Taps Rachel Brosnahan as Creative Consultant for New “Up Close and Sensitive” Digital Campaign
09 . 10 .2020
Press release
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting